Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.PubMedGoogle Scholar
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998;352:837–53.Google Scholar
Bots M, Stroobants AK, Delzenne B, Soeters MR, de Vries JE, Weykamp CW, et al. Two novel haemoglobin variants that affect haemoglobin A1c measurement by ion-exchange chromatography. Clin Chem Lab Med 2015;53:1465–71.PubMedGoogle Scholar
Benítez IC, Lameiro PC, Ropero P, De la Osa JJ, Fernández FG, Ortiz AM. Hemoglobin Valme HBB:c.124T>G:A new hemoglobin variant with diminished oxygen affinity causes interference in hemoglobin A1c measurement in an automated ion-exchange HPLC method. Clin Chem Lab Med 2015;53:e211–3.Google Scholar
Cabannes R, Renaud R, Mauran A, Pennors H, Charlesworth D, Price BG, et al. Two fast hemoglobins in Ivory-Coast: Hb K Woolwich and a new hemoglobin Hb J Abidjan (alpha-51 Gly-Asp). Nouv Rev Fr Hematol 1972;12:289–300.Google Scholar
Lacan P, Moreau M, Becchi M, Zanella-Cleon I, Aubry M, Louis JJ, et al. Two new hemoglobin variants: Hb Brem-sur-Mer [beta9(A6)Ser–>Tyr] and Hb Passy [alpha81(F2)Ser–>Pro (alpha2)]. Hemoglobin 2005;29:69–75.CrossrefPubMedGoogle Scholar
Rohlfing C, Connolly S, Hanson S, Higgins T, Little RR. Validation of the use of trinity biotech ultra2 as a comparative method for hemoglobin A1c measurements in the presence of HbE and HbD-Punjab traits. Clin Chem 2017;63:608–10.CrossrefPubMedGoogle Scholar
Ji L, Yu J, Zhou Y, Xia Y, Xu A, Li W, et al. Erroneous HbA1c measurements in the presence of β-thalassemia and common Chinese hemoglobin variants. Clin Chem Lab Med 2015;53:1451–8.PubMedGoogle Scholar
About the article
Published Online: 2019-02-02
Published in Print: 2019-07-26
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.